Ventricular pacing to augment atrial natriuretic hormone production

• US 9,592,390 B2
• Filed: 08/12/2015
• Issued: 03/14/2017
• Est. Priority Date: 12/15/2009
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stahmann, Jeffrey E., Wariar, Ramesh, Ruble, Stephen B.
• Primary Examiner(s): VOORHEES, CATHERINE M
• Application Number:
  US14/824,885
• Publication Number:
  US 20150343210A1
• Time in Patent Office: 580 Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3629 in combination with non-electric therapy
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters

Abstract

Intermittent delivery of ventricular pacing pulses synchronized to occur during an atrial diastole time period can be used to provide atrial stretch therapy and augment the production and release of atrial natriuretic hormone.

Claims

1. A method, comprising:

monitoring a first physiological parameter of a subject;

detecting whether the first physiological parameter meets a first criteria for triggering use of an atrial stretch therapy mode by a cardiac rhythm management device; and

responding to detecting that the first physiological parameter meets the first criteria by switching the cardiac rhythm management device from a first operating mode to the atrial stretch therapy mode, the atrial stretch therapy mode configured to time delivery of a pace so that;

(1) delivery of the pace results in a substantial overlap of ventricular systole and atrial systole, and (2) a ventricular contraction occurs before or substantially concurrent with an atrial contraction during the same cardiac cycle.

2. The method of claim 1, further including:

monitoring a second physiological parameter of the subject; and

responding to detecting that the first physiological parameter meets the first criteria value by detecting whether the second physiological parameter meets a second criteria for limiting use of the atrial stretch therapy mode.

3. The method of claim 2, further including:

responding to detecting that the second physiological parameter meets the second criteria by maintaining the cardiac rhythm management device in the first operating mode and avoid switching to the atrial stretch therapy mode.

4. The method of claim 1, wherein the processor is configured to time delivery of the pace, when in the atrial stretch therapy mode, to cause atrioventricular valve closure during at least one of:

early atrial systole or a specified period of time before atrial systole.

5. The method of claim 1, further including:

a cardiac pacing circuit coupled to the processor and configured to deliver the pace to a chamber of a heart, wherein the processor is configured to time delivery of the pace, when in the atrial stretch therapy mode, so the ventricular contraction occurs before the atrial contraction during the same cardiac cycle.

6. The method of claim 1, further including:

a cardiac pacing circuit coupled to the processor and configured to deliver the pace to a chamber of a heart, wherein the processor is configured to time delivery of the pace, when in the atrial stretch therapy mode, so the ventricular contraction occurs substantially concurrent with the atrial contraction during the same cardiac cycle.

7. The method of claim 1, further including:

adjusting use of the atrial stretch therapy mode using information about the measure of the first physiologic parameter.

8. The method of claim 1, wherein the first physiologic parameter includes at least one of:

systemic blood pressure, cardiac output, and fluid status.

9. An apparatus comprising:

a cardiac rhythm management device including;

a cardiac pacing circuit configured to deliver a pacing pulse to a chamber of a heart; and

a processor, coupled to the cardiac pacing circuit, the processor configured to include a first therapy delivery mode and an atrial stretch therapy mode, the processor configured to;

switch from the first therapy delivery mode to the atrial stretch therapy mode based upon a triggering event; and

time delivery of the pacing pulse to the chamber of the heart, when in the atrial stretch therapy mode, so that;

(1) delivery of the pacing pulse results in a substantial overlap of ventricular systole and atrial systole, and (2) a ventricular contraction occurs before or substantially concurrent with an atrial contraction during the same cardiac cycle.

10. The apparatus of claim 9, further including:

a physiologic sensor, coupled to the processor, the physiologic sensor configured to measure a physiologic parameter of a subject;

wherein the triggering event at least partially includes when the measure of the physiologic parameter meets a specified threshold value, and wherein the processor is configured to adjust use of the atrial stretch therapy mode using information about the measure of the physiologic parameter.

11. The apparatus of claim 9, further including:

a physical activity sensor, coupled to the processor, the physical activity sensor configured to detect physical activity of a subject;

wherein the triggering event at least partially includes when the measure of the physical activity is above a specified threshold value.

12. The apparatus of claim 9, further including:

a cardiac output monitor circuit, coupled to the processor, the cardiac output monitor circuit configured to provide an indication of a cardiac output of a subject; and

wherein the triggering event at least partially includes when the indication of the cardiac output is below a specified threshold value.

13. The apparatus of claim 9, wherein, when in the atrial stretch therapy mode, the processor is configured to deliver the pacing pulse intermittently, including:

delivering the pacing pulse a specified number of times per a specified number of cycles.

14. The apparatus of claim 9, wherein, when in the atrial stretch therapy mode, the processor is configured to deliver the pacing pulse intermittently, including:

delivering the pacing pulse a specified number of times per a specified time period.

15. The apparatus of claim 9, wherein, when in the atrial stretch therapy mode, the processor is configured to deliver the pacing pulse intermittently, including:

delivering one or more pacing pulse sessions over a time period.

16. An apparatus comprising:

a cardiac rhythm management device comprising;

a cardiac pacing circuit configured to deliver a pacing pulse to a chamber of a heart; and

a processor circuit, coupled to the cardiac pacing circuit, the processor configured to include an atrial stretch therapy mode, the processor configured to;

receive first physiological data about a subject, the first physiological data including at least systemic blood pressure of the subject;

time delivery of the pacing pulse, when in the atrial stretch therapy mode, so that;

(1) delivery of the pacing pulse results in a substantial overlap of ventricular systole and atrial systole, and (2) a ventricular contraction occurs before or substantially concurrent with an atrial contraction during the same cardiac cycle; and

limit use of the atrial stretch therapy mode when the first physiological data meets a first criteria.

17. The apparatus of claim 16, wherein the processor is configured to:

detect, based on the systemic blood pressure of the subject, an atrial event; and

time delivery of the pacing pulse, when in the atrial stretch therapy mode, so that the pacing pulse is synchronized to the systemic blood pressure.

18. The apparatus of claim 16, wherein the processor is configured to:

receive second physiological data about the subject; and

limit use of the atrial stretch therapy mode when the second physiological data meets a second criteria.